David Hunter

Professor David Hunter is the Florance and Cope Chair of Rheumatology and Co-Director of the Sydney Musculoskeletal Health Flagship at the University of Sydney. He is a leading clinician-researcher in osteoarthritis (OA), with over 600 peer-reviewed publications and recognition as the world’s top OA expert on Expertscape (2014–current). His work spans clinical and translational research, focusing on OA epidemiology, imaging, novel therapies, and chronic disease management systems.

• Co-Director, Sydney Musculoskeletal Health Flagship
• Editor-in-Chief, Osteoarthritis and Cartilage
• Section Editor, UpToDate Osteoarthritis
• Academic Affiliation: University of Sydney, Kolling Institute

Research Interests:
Professor Hunter’s research emphasizes improving OA understanding and patient quality of life. Key areas include:

• Epidemiology of osteoarthritis
• Imaging (MRI, ultrasound) for structural and functional analysis
• Novel therapeutic interventions (e.g., platelet-rich plasma, disease-modifying drugs)
• Health service delivery for chronic disease
• Patient-reported outcomes in clinical trials
• Genetic and environmental risk factors for OA progression
• Biomechanics and hip/knee joint dynamics

Article Trends:
His recent work explores OA through clinical trials, imaging biomarkers, and health service innovations. Notable themes include:

• Virtual endpoints for knee replacement outcomes
• Diet and exercise interventions for overweight OA patients
• Comparative effectiveness of surgical vs. non-surgical therapies
• Role of muscle quality and radiomics in OA development
• Psychosocial factors in pain management
• Global OA guidelines and patient-centric care

Scientific Awards:

• OARSI Clinical Researcher Award (2019)
• Vice-Chancellor’s Award for Research Excellence (2019)
• Distinguished Professorial Achievement Award, University of Sydney (2014)
• World-leading OA expert, Expertscape (2014–current)

Advising and Grants:
He supervises multiple PhD students working on OA-related projects, including:

• Medical and allied health practitioner concordance in OA management
• Factors affecting discharge after hip/knee arthroplasty
• Pentosan Polysulfate Sodium trials for knee OA
• Communication frameworks for OA empowerment

His grants address cost-effectiveness of OA interventions, digital health tools, and multidisciplinary care programs, reflecting his commitment to translating research into clinical practice.

Labs and Teams:
He leads the osteoarthritis team at the Kolling Institute, collaborating with Sydney Musculoskeletal Health Flagship. His team specializes in:

• Osteoarthritis clinical trials
• MRI and ultrasound biomarker analysis
• Health service delivery optimization
• Global OA guideline development